Skip to main content
. 2005 Oct 21;61(1):34–40. doi: 10.1136/thx.2005.040881

Table 4 Asthma and hay fever in women according to HRT use stratified by BMI in tertiles.

No HRT (%) HRT (%) OR (95% CI)* p value
Lower tertile BMI <22.76 (n = 716)
 Asthma† 5.3 12.0 2.28 (1.18 to 4.40)** 0.014
 Wheeze‡ 14.9 25.8 1.85 (1.16 to 2.96)†† 0.010
 Hay fever§ 20.7 29.7 2.06 (1.33 to 3.19)‡‡ 0.001
 
Medium tertile BMI 22.76–25.71 (n = 736)
 Asthma† 5.6 6.3 1.28 (0.61 to 2.71)** 0.513
 Wheeze‡ 15.0 19.7 1.56 (0.95 to 2.54)†† 0.076
 Hay fever§ 23.1 25.3 1.20 (0.79 to 1.84)‡‡ 0.395
 
Upper tertile BMI >25.71 (n = 709)
 Asthma† 10.6 12.4 1.31 (0.71 to 2.42)** 0.382
 Wheeze‡ 24.1 26.7 1.28 (0.80 to 2.06)†† 0.302
 Hay fever§ 25.0 26.9 1.39 (0.89 to 2.17)‡‡ 0.153

*From logistic regression models with adjustment for smoking habits, BMI (within tertile), age, centre, and type of dwelling (as a proxy for social class).

†Asthma medication and/or asthma attacks in the last 12 months.

‡Wheeze in the last 12 months.

§Hay fever or nasal allergies.

**Interaction in effect of HRT on asthma between lean and normal/overweight women pinteraction = 0.020.

††Interaction in effect of HRT on wheeze between lean and normal/overweight women pinteraction = 0.026.

‡‡Interaction in effect of HRT on hay fever between lean and normal/overweight women pinteraction = 0.076.